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Climate change is one of the greatest threats to human health in the 21st century. Climate directly impacts health
through climatic extremes, air quality, sea-level rise, and multifaceted influences on food production systems and
water resources. Climate also affects infectious diseases, which have played a significant role in human history,
impacting the rise and fall of civilizations and facilitating the conquest of new territories. Our review highlights
significant regional changes in vector and pathogen distribution reported in temperate, peri-Arctic, Arctic, and
tropical highland regions during recent decades, changes that have been anticipated by scientists worldwide. Further
future changes are likely if we fail to mitigate and adapt to climate change. Many key factors affect the spread and
severity of human diseases, including mobility of people, animals, and goods; control measures in place; availability
of effective drugs; quality of public health services; human behavior; and political stability and conflicts. With drug
and insecticide resistance on the rise, significant funding and research efforts must to be maintained to continue the
battle against existing and emerging diseases, particularly those that are vector borne.
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Introduction
Climate change is considered one of the greatest
threats to human health by the World Health Orga-
nization. The rate of global warming which has
occurred during recent decades has been unprece-
dentedover the pastmillennium,1,2 and there is con-
sensus in the scientific community that the cause
is increasing anthropogenic emissions of green-
house gases.2 Climate changedirectly impactshealth
through long-term changes in rainfall and tem-
perature, climatic extremes (heatwaves, hurricanes,
and flash floods), air quality, sea-level rise in low-
land coastal regions, and multifaceted influences
on food production systems and water resources.3
Since 2016, the Lancet countdown initiative has
been tracking progress on health and climate change
issues related to implementation of the Paris cli-
mate agreement,4,5 providing a broad overview of
climate change impacts on health. In this review, we
focus specifically on the impact of climate change
on infectious diseases. This impact is likely to be
significant; a recent systematic review of European
human and domestic animal pathogens suggested
that nearly two-thirds were climate sensitive, many
to more than one climate driver.6
Infectious diseases of humans and animals have
played a significant role in history. Plague outbreaks
in Rome (2nd century BCE) and Athens (5th cen-
tury BCE) were reported in biblical records, and the
Black Death epidemic which struck Europe during
the 14th century wiped out between a third and
a half of the European population.7 Subsequently,
conquests of the Americas, Australia, and South
Africa by Europeans were facilitated by importation
of germs such as measles and smallpox that dec-
imated fully susceptible indigenous populations.8
More recently, in2014–2016, the largest yetobserved
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Ebola outbreak devastated vulnerable populations
in Sierra Leone, Liberia, and Guinea.9 This was fol-
lowed by the Zika virus (ZIKV) epidemic affecting
Latin America, the Carribean, parts of Southeast
Asia, and Africa in 2015–2016. Over the summer of
2017, verymoderate autochthonous transmissionof
ZIKV also took place in southern Florida and Texas,
in the United States, a wealthy country.
The negative impact of infectious diseases on
health and well-being is intrinsically linked to a
combination of multiple stressors or drivers such as
poor sanitation, access to clean water and food, the
quality of public health services, political instability
and conflict, drug resistance, and animal and/or
human population movements.10 How we shape
and adapt to the environment, through our impact
on land use (deforestation/afforestation and agri-
cultural activities), the building of artificial water
bodies or dams,11 and the measures undertaken to
control infectious diseases such as vaccine and drug
development, insecticide spraying, distribution of
impregnated bed nets, and development of rapid
diagnostic tests, are also critical factors affecting
infectious disease transmission. Climate has a direct
impact on the dynamics of a subset of infectious
diseases, including vector-borne diseases (VBDs),
some water-borne diseases such as cholera, and
other soil-borne and food-borne pathogens.6
Climate also has multiple indirect effects through
socioeconomic factors; as one example, flooding
can hamper disease control measures in place,
including vector control.12
Infectious VBDs are mainly transmitted by
arthropod vectors, which are particularly sensitive
to changes in climate, for a number of reasons.
Arthropods are ectothermic, with their internal
temperature regulated by external environmental
conditions. Their larval development stage gener-
ally requires the presence of bodies of water and/or
specific humidity conditions. Vector biting rates
tend to increase with temperature up to an upper
threshold, after which they decrease.13 The devel-
opment and replication of pathogens transmitted
within vectors (the extrinsic incubation period or
EIP) or in the environment also occurs faster at
high temperatures.14 Furthermore, vector develop-
ment and survival is significantly affected by tem-
perature conditions.15 The entomological param-
eters affected by rainfall and temperature can be
summarized using the maximum daily reproduc-
tive rate of the disease: the vectorial capacity.16 The
optimal temperature range for disease transmission
varies depending upon the vector–pathogen combi-
nation being studied; however, vectorial capacities
of themost harmful tropical VBDs consistently peak
at relatively high temperatures.17
The evidence suggests that future climate change,
if not mitigated, will very likely impact the length of
the transmission season and the geographical range
of a significant proportion of infectious diseases.18
On a broader scale, climate change will reshuffle
the geographical distribution of animal species, and
one of the most prominent illustrations of this is
an image of a starving polar bear, released by the
National Geographic Society in December 2017.
The direct impact of climate change on habitat, and
therefore ecosystemchange, combinedwith increas-
ing anthropogenic pressure on the natural envi-
ronment, is severely affecting biodiversity, further
impacting the emergence and transmission of infec-
tious diseases.19 An important point to emphasize
is that of attribution and detection: how can recent
spatiotemporal changes in infectious diseases be
attributed, wholly or in part, to long-term anthro-
pogenic climate change? This is a complicated ques-
tion to answer, hindered by the lack of good quality
health and climate datasets over long time periods,
by the various nonclimatic factors at play and by
the influence of natural climate variability modes
that are now occurring in a warmer background,
such as the crucial El Nin˜o Southern Oscillation.
The latter issue led to controversy over the attri-
bution of climate change effects on recent malaria
changes observed in the East African highlands.20–26
However, there is clear evidence that climate change
has already affected the latitudinal and altitudinal
ranges of avianmalaria in wild birds.27,28 The health
of wild animals, particularly birds, is assumed to
be a better indicator of early climate change effects
because very little or no controlmeasures are under-
taken to protect them.29,30 VBDs seriously affect the
health of domestic animals and livestock (e.g., try-
panosomiasis, Rift Valley Fever, and bluetongue),
and consequently, climate changewill also indirectly
affect ourhealth through itsmultifaceted impactson
food security, including livestock and plant crops.
There is a need to pragmatically estimate and
discuss the importance of climate with respect to
other critical factors affecting the spatiotemporal
dynamics of infectious diseases. In this review,
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we discuss recent trends and advances in our
understanding of the impact of recent and future
climate change on VBD dynamics. We mainly
focus on VBDs, as they are expected to be the most
climate-sensitive subset of all infectious diseases and
have sensitivity to the greatest number of climate
drivers.6 As quantitative detection and attribution
of climate change impacts is impossible for most
infectious diseases,31 we highlight recently observed
trends in temperate, Arctic, and tropical-altitude
regions which have already experienced significant
changes in climate, and for which one would
consequently expect some evidence of early climate
change impacts on VBD burden. We also discuss
progress in state-of-the-art future risk scenarios for
VBDs, methodological issues, and the relevance of
this research to policy makers and governmental
health agencies.
Recent studies
The global burden of infectious diseases has sig-
nificantly declined over past decades, thanks to
the development of modern medicine, the com-
bination of poverty alleviation and socioeconomic
development, and the deployment of more effec-
tive intervention and control measures.32 How-
ever, improvement at a global scale masks large
changes occurring regionally. From 1990 to 2012,
the frequency of academic studies referencing a
disease-climate link has nearly doubled.33 In the fol-
lowing, we will discuss important emerging exam-
ples of VBDs affecting humans and animals.
Malaria
Human malaria is caused by five species of plas-
modium parasites and is transmitted by female
Anophelesmosquitoes. The tropical form, Plasmod-
ium falciparum, causes themost severe clinical form
of malaria and is widespread in the tropics and
sub-Saharan Africa, causing about 90% of global
malaria cases.34 The more temperate form, Plas-
modium vivax, used to be prevalent in Europe, but
control measures such as drainage of marshes
and spraying of dichlorodiphenyltrichloroethane
(DDT) led to its disappearance following World
War II. Overall, Anopheles mosquitoes need ade-
quate rainfall to create breeding sites that will not
dry up or wash away over a 9–12 day period. Repli-
cation of the parasite within the mosquito vector
requires a minimum air temperature of about 15–
16 °C forP. vivax and 19–20 °C forP. falciparum.35,36
Increased temperatures that are close to the upper
limit for vector and pathogen survival (roughly
about 35–37 °C) tend to reduce transmission, while
increased variation in daily temperatures near the
lower limit tends to increase transmission.35,37,38
Precipitation creates adequate vector breeding sites,
and the relationship between temperature, rainfall,
and malaria is also highly vector-specific.24,39
Economic development and the implementation
of stringent control and interventionmeasures have
driven a large global decrease in the spatial distribu-
tion and endemicity of the disease over the past cen-
tury. This is despite rising global temperatures,40,41
thanks to significant funding efforts to control and
reduce malaria burden. Current malaria interven-
tions have the ultimate goal of malaria elimination,
but are unlikely to be capable of eradicating the dis-
ease completely in all regions of Africa, even in cur-
rent climate conditions.42 The number of reported
human infections with P. falciparum is increasing
in tropical highland regions across the globe, for
example, in Eastern Africa,24,25,43–46 Nepal,47–50 and
Colombia.43 Competent malaria vectors have also
recently been found at higher altitudes.47,49,51–54
This has serious implications for indigenous high-
land human populations that usually lack protective
immunity and aremore vulnerable to severemalaria
morbidity andmortality. The extraordinary biolog-
ical complexity of the malaria parasite has hindered
the development of effective vaccines, even though
it is well known that transmission-blocking antipar-
asite immune responses exist. RTS,S/AS01 is the
most advanced malaria vaccine candidate currently
in development, and is due to be rolled out in trials
in three African countries in 2018.55
Other malaria parasites also affect animals,
including reptiles, birds27,28 (with infections
recently reported as far north as Alaska56), and
some mammals. Occasionally, humans are infected
by Plasmodium species that normally infect animals
(e.g., Plasmodium knowlesi, usually transmitted in
small primates).57 Fully susceptible penguins have
been severely impacted by avianmalaria in UK zoos
in 2016. This might be related to both conducive
environmental conditions for both the vector
and parasite, and the importation of parasites in
migratory birds.
Several studies have estimated the potential
impact of climate change on the distribution
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and severity of P. falciparum human malaria at
global and regional scales using malaria models
driven by climate model simulations.58–64 Overall,
future climate conditions in these simulations are
increasingly suitable for malaria transmission in
tropical highland regions, in particular the East
African highlands; the malaria epidemic fringe
is generally predicted to shift southward in sub-
Saharan Africa; and temperature conditions might
become unbearable for the mosquito vectors in the
warmer tropical plains of the Sahel by the end of
the 21st century. Most of these studies only estimate
the impact of climate on malaria without account-
ing for important socioeconomic factors;40,62,65 eco-
nomic development and intervention might offset
and counteract climate-induced trends.66
Even if future climate conditions become suit-
able for malaria transmission in Europe, temper-
ate Asia, and the United States (as in the past),67 a
large epidemic is very unlikely to happen in these
regions given the availability of antimalarial drugs
and the standard of public health services. However,
local transmission of P. vivax occurred in Greece in
2009–2010 in association with large cuts in govern-
ment spending due to the economic crisis, human
migration, and the heatwave that struck southeast-
ernEurope.68 Very limitedautochthonous transmis-
sion of P. vivax in Spain was recently reported,69 and
a few puzzling, very likely nosocomial, P. falciparum
infections were also reported in Italy in 2017.70
This is a major warning for our health services and
decision makers given recent economic climate and
austerity measures.71 A dramatic re-emergence of
malaria cases since 2000 has been observed in the
temperate Anhui province of China, prior to which
there was very low-level endemicity. This sudden
increase is related to climatic conditions, with rain-
fall strongly associated withmalaria transmission.72
Interestingly, clinicians emphasized that they expect
climate change to affect the burden of infectious dis-
eases in the area, despite adequate hospital infras-
tructure to tackle emerging infectious diseases.73
The most worrying risk factor affecting malaria
is that mosquitoes and parasites are develop-
ing resistance to the weapons we use to fight
them. Vector resistance to insecticide (DDT), com-
bined with parasite resistance to antimalarial drugs
(chloroquine mainly and artemisinin to a lesser
extent), is on the rise.74 Drug and insecticide
resistance might counteract the amazing progress
achieved by malaria control measures over the past
15 years. Additionally, most malaria resurgences
over the 20th century were related to weaken-
ing of malaria control measures; thus, there is an
urgent need to deliver practical solutions to finan-
cial andoperational threats to sustain recent success-
ful malaria control programs.75,76 Sadly, there were
216 million cases of malaria worldwide in 2016, an
increaseoffivemillion comparedwith2015. In some
countries and regions, particularly in sub-Saharan
Africa, malaria is on the rise again.34
Important arboviruses: dengue, chikungunya,
yellow fever, Zika, and West Nile
The arboviruses dengue, Zika, yellow fever, and
chikungunya are transmitted by Aedes mosquito
species; Aedes albopictus (the Asian tiger mosquito)
and Aedes aegypti (the yellow fever mosquito) are
thought to be theirmain competent vectors.Dengue
is the most rapidly spreading mosquito-borne dis-
ease, with a 30-fold increase in global incidence over
the past 50 years77 and an estimated 100–390million
dengue infections reported worldwide each year.78
These vectors have spread into new areas due to
globalization and international trade, for example,
importation of used tires and plants from Asia.79–82
This group of diseases poses serious concerns for
public health services, given the heavy burden they
still cause in Asia and South America,78 the large
potential of Aedesmosquitoes to transmit viruses in
urban settings,83,84 and the risk of autochthonous
transmission of diseases by returning infected trav-
elers in vector-endemic regions.85,86
No fully effective vaccine has yet been devel-
oped for these diseases87,88 but such work is in
progress.89,90 Recent trends are worrying, with out-
breaks of dengue reported in the United States,91
Madeira in 2012,92 autochthonous transmission of
both dengue and chikungunya reported in southern
France in 2010 and 2014,93,94 local dengue transmis-
sion in Croatia in 2010,95 the largest dengue out-
break reported in China in 2014,96 and the first local
dengue case reported in Japan in over 70 years in
2014.97 Chikungunya is also on the rise, with an out-
break reported in Italy in 200798 and 2017, the first
local transmissionof this disease in theUnited States
in 2014,99 and recent epidemics in the Caribbean,
and Central and South American regions.100
Ae. aegypti is considered to be the most efficient
urban vector of dengue in tropical and subtropical
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settings, whileAe. albopictus ismore adapted to tem-
perate climate regions (e.g., United States, Europe,
Japan, and parts of China) and is more efficient
at transmitting chikungunya virus.101–103 There is
increasing evidence that (1) recent climate change
has already favored Ae. albopictus to settling in tem-
perate regions once it has been introduced, due
to favorable overwintering and annual temperature
conditions; (2) the mosquito has not yet filled its
potential ecological niche; and (3) future climate
changemight sustain its establishment at higher lati-
tudes in temperate regions.104–114 The current distri-
bution ofAe. aegypti is more restricted to the tropics
and subtropics,78,115 and future scenarios suggest a
moderate latitudinal shift in its potential ecologi-
cal niche because its eggs do not tolerate temperate
winters.103,113,114 However, it is noteworthy that Ae.
aegyptiused tobepresent around theMediterranean
basin andwas reported as farnorth asBrest inFrance
andOdessa in Ukraine afterWorldWar II;116 conse-
quently, these scenariosmight be slightly optimistic.
Several mechanistic and statistical disease mod-
eling approaches have been employed to project
the future distribution of dengue.35,113,117–120 These
studies generally project an increase in the overall
burden of dengue, but a clear consensus is lacking
regarding regions of the world where transmission
is expected to intensify and expand or contract and
diminish.101 A recent study highlights that future
climate conditions might become increasingly suit-
able for dengue transmission in southern Europe in
the summer.121 Recent projections carried out for
chikungunya show increasingly suitable climatic
conditions in temperate regions of Western Europe
(France, the Benelux Union, and Germany) for the
future.122,123 The expected increase in urbanization
(especially in urban slums) and increasing trends
in international trade and travel must be expected
to amplify, rather than reduce, future temperature
effects on these diseases.31
In 2015, an outbreak of ZIKV hit Brazil before
spreading to most countries in South and Central
America and the Caribbean. In subsequent years,
ZIKV circulated in a few countries in Africa and
Southeast Asia. In summer 2017, limited and local
transmission occurred in Texas and Florida in the
southern United States. The virus was very likely
introduced into northeastern Brazil by a traveler
in 2014; the first human case was subsequently
detected in May 2015.124 ZIKV is primarily trans-
mitted by the bites of infected Aedesmosquitoes,125
and it can also be sexually transmitted. It causes
severe neurological complications such as micro-
cephaly in unborn children,126 and less frequently, a
paralytic autoimmune disease calledGuillain–Barre´
syndrome. WHO declared ZIKV as a Public Health
Emergency of International Concern in February
2016. The end of this emergency was declared in
November 2016 when the number of infected cases
significantly declined.
When the outbreak started, scientists emphasized
that the “2015 El Nin˜o caused exceptional climatic
conditions in north-eastern South America during
winter and spring in the Southern Hemisphere.”127
This statement was in agreement with previous
studies demonstrating a significant link between
the El Nin˜o climate phenomenon, regional climate
anomalies, and dengue epidemics in South America
and Southeast Asia.128,129 The positive phase of the
El Nin˜o Southern Oscillation has been associated
with many infectious disease outbreaks worldwide,
including Rift Valley fever, malaria, and cholera in
East Africa; increased risk of arbovirus and malaria
transmission in Latin America and Southeast Asia;
and outbreaks of malaria and cholera in India, and
this is just the tip of the iceberg.130,131 El Nin˜o is a
natural climatic oscillation; however, it now occurs
with a warmer sea surface temperature background
and this poses serious health implications for the
future, inparticular in the tropical belt.132 A rainfall-
and temperature-driven model of the disease basic
reproduction ratio (R0, the number of secondary
infections produced by a single case introduced
into a completely susceptible population) for ZIKV
later confirmed that climatic conditions related to El
Nin˜o 2015–16were optimal for themosquito-borne
transmission risk of ZIKV in Latin America.133 The
simulated transmission risk ofZIKV inSouthAmer-
ica in 2015 was the largest since the 1950s. Risk
maps also reveal potential transmission risk in the
southern states of the United States, the south-
ern provinces of China, where dengue transmission
has already been observed, and to a lesser extent
in southern Europe. This work also predicted the
spread of ZIKV to Angola; this country was plagued
by yellow fever during the Latin American out-
break. ZIKV was found circulating in Angola in
subsequent years.134 Recent modeling work cor-
roborates these findings at the city-scale; namely
that climatic conditions were optimal for ZIKV
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transmission in Feira de Santana, Brazil in 2015–
16.135 Another study highlights the worsening addi-
tional effect of an earthquake that hit Ecuador in
2016.136 Importantly,Mun˜oz and colleagues utilized
a similar R0 model driven by operational seasonal
climate forecasts to show that the ZIKV epidemic
could have been theoretically forecast one month in
advance in Brazil in 2015.137
Many other factors synergistically contributed to
the severity of the ZIKV epidemic in Latin Amer-
ica in 2015–16. South American and Caribbean
populations were very likely fully susceptible to
infection before the virus was introduced.138 Addi-
tionally, storage of water in containers during
droughts in urban slums combinedwith the anthro-
pophilic behavior of Ae. aegypti, political instabil-
ities, human behavior, and other natural disasters
very likely led to the epidemic.139 It is very diffi-
cult to develop future scenarios for ZIKV risk, given
that the level of herd immunity following the large-
scale exposure of human populations should pre-
vent a large outbreak occurring in South America
within theupcomingdecade.138 However, semitrop-
ical and temperate regions where populations have
never been exposed to ZIKV and where competent
Aedesvectors and suitable environmental conditions
co-occur should be stringently surveyed by public
health services.
Yellow fever has also re-emerged in the Demo-
cratic Republic of the Congo andAngola in 2015–16
and in Brazil in 2017–18. Theoretically, yellow fever
should not be a problem, given the availability of an
effective vaccine that provides lifelong immunity to
infection. However, the recent epidemics in Africa
and Brazil, combined with the limited number of
vaccine manufacturers approved by WHO, signifi-
cantly depleted the global stock of available vaccine.
Surveillance should concentrate on urban areas and
slums where Ae. aegypti, the anthropophilic yellow
fever mosquito, is present.
West Nile Virus (WNV), which infects birds,
humans, horses, and other mammals, is the most
widely distributed encephalitic flavivirus. WNV is
mainly transmittedbyCulexmosquitoes in all conti-
nents, except Antarctica. Many studies have already
discussed the importance of weather and climate in
drivingWNV epidemics.140–143 WNVhas circulated
in Africa since the 1930s and first appeared in New
York City in the United States in 1999.WNV rapidly
spread to four northeasternU.S. states, finally reach-
ing California during summer 2003.144 Circulation
in humans and horses was reported in the western
Mediterranean region and southern Russia in the
early 1960s, Belarus and Ukraine in the 1970s and
1980s, and a large WNV outbreak was reported in
1996–97 in Romania, followed by another epidemic
wave in Russia in 1999.145 Large WNV epidemics
were subsequently reported in Russia during the late
2000s146 and in the Balkan area in the early 2010s.
Milder winter conditions, combined with droughts
during the boreal spring season, were associated
with increased risk of WNV transmission by urban
mosquitoes in the United States.141 Extreme rainfall
events were also associated with increased risk of
WNV transmission. Given that the extrinsic incu-
bation period of WNV in Culex mosquitoes short-
ens significantly when temperature increases,14
climate change will undoubtedly impact future
WNV epidemics.
Tick-borne diseases
Ixodes ticks can transmit bacteria from the genus
Borrelia (causing Lyme disease) and Flaviviridae
virus (such as tick-borne encephalitis, TBE). Lyme
disease is the most common VBD affecting humans
in the temperate Northern Hemisphere. Rainfall,
moisture, and temperature affect the life cycle and
habitat of Ixodes ticks, and they prefer habitats with
at least 85% relative humidity and search for hosts
when the temperature exceeds about 7 °C.147
Ixodes ricinus, the sheep tick, has expanded its
geographical range and seasonal activity in Europe
over the past decade,148 including its distribution,
shifting farther north in Sweden and Norway. This
northern shift and increase in activity is related to
milder winters and prolonged spring and autumn
seasons in the 1990s, combined with increased veg-
etative cover and the spread of deer carrying ticks
into newly suitable regions.149 Similar trends have
been observed in the Baltic countries and north-
ern parts of Poland. In the Alps and the Carpathian
mountains of central Europe, an altitudinal shift
of I. ricinus from about 700 m in the 1950s to
1200 m in the 2000s has also been reported by
field entomologists.150–152 Future scenarios indicate
a potential further expansion of I. ricinus in north-
ern and eastern Europe.153
The number of Lyme disease cases in Europe has
steadily increased fromabout 3000 in the early 1990s
to 35,000 in the late 2000s.154 In the United States,
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similar trends have been observed. Two main tick
species, Ixodes scapularis, the deer tick on the east
coast, and Ixodes pacificus, on the west coast, trans-
mit Lyme disease in the United States; they both
spread farther north between 1996 and 2015.155
The number of Lyme disease cases has more than
doubled in the United States since the 1990s, and
Lyme disease is now believed to affect about 300,000
Americans annually. Ogden and others have warned
about the potential northern expansion of I. scapu-
laris and the diseases it transmits into Canada for
more than a decade.156,157 The first infected ticks
were found on the Ontario shore of Lake Erie in
the early 1990s. Ixodes ticks have since spread far-
ther north intoOntario, parts of Quebec,Manitoba,
New Brunswick, and Nova Scotia.158 The incidence
of Lyme disease has increased from 0.4 to 2.7 per
100,000 population from 2009 to 2016 in Canada;
88% of cases were reported in the provinces of Que-
bec, Ontario, and Nova Scotia.159 Even under an
optimistic climate change scenario, for which the
global warming increase is limited to 1.5 °C, consis-
tent with the Paris agreement target, Lyme disease
was found in simulations to spread farther north
in Canada in the future.160 Northern Russia has also
experienced an increase in the Ixodes tickpopulation
and in TBE cases over the past decades.161,162 In par-
ticular, a 50-fold rise in TBE incidence was reported
for the far northern province of Arkhangelsk Oblast
during the 2000s compared with the 1980s. There
was also a distinct correlation between TBE inci-
dence and increases in mean annual air tempera-
tures from 1990 to 2009.162
Other important tick-borne pathogens (babesio-
sis, Crimean-Congo hemorrhagic fever, and rick-
ettsioses) are also climate-sensitive (for more
detailed reviews, see Refs. 148 and 163). The pat-
terns described for tick-borne diseases, including
an altitudinal and latitudinal shift of Ixodes ticks
and the diseases they transmit, have been observed
in different temperate and peri-Arctic regions of the
Northern Hemisphere during the past decade. This
is related to the direct impact of climate change on
Ixodes tick habitats, with more conducive tempera-
ture conditions and milder winters. Similar trends
are likely for these regions in the future if we fail
to mitigate and adapt to climate change. However,
this is not the only factor causing tick spread into
new habitats; other anthropogenic and natural fac-
tors need to be considered.Wild animal hosts (deer,
other cervids, birds, and rodents) also carry tick
vectors into new regions, and afforestation and land
and wildlife management are extremely important
potential drivers.148,164 The expansion of towns and
urban areas into green zones, combined with an
increasing numbers of trekkers and wildlife lovers,
is also changing human and domestic animal expo-
sure to tick-borne pathogens.
Midge-borne diseases: the example of
bluetongue emergence in northern Europe
Bluetongue is a noncontagious, midge-borne viral
disease affecting ruminants (mainly sheep and less
frequently cattle, goats, antelope, deer, camel, and
dromedaries). Bluetongue virus (BTV) is transmit-
ted by Culicoides biting midges. Its emergence in
northern Europe in 2006 is considered a prime
example of early climate change impacts onVBD.165
The Afrotropical midge vector Culicoides imicola
was responsible for a large BTV outbreak in south-
ern Europe in 1998.166 At that time, it was not
expected that indigenous Culicoides midges (Culi-
coides obsoletus) could transmit BTV in the cold
climate of northern Europe and Scandinavia. But in
2006, BTV emerged in northern European farms.
From 2006 to 2009, tens of thousands of farms
were unexpectedly affected by BTV. This outbreak
resulted in a huge financial cost to the European
farming industry: about €164–175 million in the
Netherlands alone in 2007.167 It was brought to
an end by a newly developed vaccine. However,
in 2015, BTV re-emerged in central and northern
France, and has been present ever since, with live-
stock movements currently restricted country-wide
in an attempt to contain the area affected.168
Modeling studies have highlighted that climate
conditions favored the spread of the Afrotropical
midge vector in southern Europe as well as increas-
ing the vectorial capacity of indigenous Culicoides
vectors to transmit BTV in northern Europe in
2006.169 This outbreak coincided with the heat-
wave that hit Europe during summer 2006 (and
caused a large increase in mortality in the elderly
human population). Furthermore, the wind disper-
sal of infectedmidges and themovement of infected
animals are important parameters to consider.170,171
Future scenarios indicate that rainfall and temper-
ature conditions will become increasingly suitable
for the transmission of BTV in northern Europe in
the far future.169
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Helminths and other parasites
In veterinary parasitology, the work of Ollerenshaw
and Rollands on Fasciola hepatica, the sheep liver
fluke, in Wales is a prime example of the impact of
weather and climate on the dynamics of parasitic
worms. The parasite develops on wet grassland, and
then infects an intermediate snail host, before being
ingested by a ruminant. F. hepatica then migrates to
the bile duct and liver of the host, before releasing
eggs which are excreted by the animal onto pasture.
The free-living stages of the parasite and the snails
themselves are favored by wet and mild/warm cli-
matic conditions on grassland.172 Transmission of
the parasite in most countries is seasonal; it takes
approximately three months for parasite stages to
develop from eggs and for the release of infective
metacercariae onto pasture to occur via the inter-
mediate snail host.172 Liver fluke causes severe mor-
bidity in sheep, reduced milk yield in dairy cat-
tle, reduced growth rates, and liver condemnation;
consequently, it has large cost implications for the
farming industry. Ollerenshaw and Rollands devel-
oped an empiricalmodel to forecast the risk of acute
fluke infections in sheep during the late 1950s. This
model relies on the frequency of rainy days, evapo-
transpiration, and temperature from spring to early
fall to forecast acute disease burden in sheep the
following winter; the model takes advantage of the
time lag associated with the life cycle of the para-
site. Themodel was able to successfully forecast epi-
demics of liver fluke in sheep in Anglesey, Wales in
the late 1950s. The model is now used operationally
by theNational AnimalDisease Information Service
to provide regional risk forecasts to UK farmers.173
Other spatial risk models based on evapotranspi-
ration data from satellite have been subsequently
developed to model the risk posed by liver fluke.174
Recent studies have shown that climatic condi-
tions are increasingly suitable for the transmission
of liver fluke in theUK,175 some temperate northern
European regions,176 and New Zealand.177 Interest-
ingly, the number of ruminants infected by liver
fluke and other helminths significantly increased
during the 2000s in the UK178 and in some Euro-
pean regions. This increase might have been caused
by the combination of increasingly suitable envi-
ronmental conditions combined with an increase in
anthelminthic drug resistance.179 Future scenarios
suggest a lengthening and intensification of the liver
fluke transmission season in northern Europe.176
Under the most extreme greenhouse gas emission
scenario (RCP8.5), fluke burden in Scotland in the
2080s might become as large as currently reported
for the most endemic region in the UK,West Wales,
and the Valleys. Similar trends are likely for the bar-
ber poleworm,Haemonchus contortus, inEurope.180
Other climate-sensitive helminths will also be sig-
nificantly affected by climate change in temperate
regions.178
Schistosomiasis is caused by five species of the
flat worm Schistosoma and requires aquatic snails
as intermediate hosts to complete its life cycle.
Its global prevalence has increased since the 1950s
largely as a result of expansion of irrigation sys-
tems in hot climates, where the snail host and par-
asite can infect human hosts. However, the recent
scaling up of distribution of the drug praziquan-
tel to school children and adults in Africa, where
most cases occur, has significantly decreased dis-
ease prevalence. The parasite and aquatic snail
require specific water temperature conditions. In
2015, the first local case of schistosomiasis was
reported in Corsica, France.181 The availability of
competent snail hosts, combined with warm sum-
mer temperature conditions, and the importationof
the parasite by an infected traveler led to the infec-
tion of several familymembers whowere swimming
in a river. Climate change is expected to signifi-
cantly increase infection risk in East Africa by 20%
over the next 20–50 years,182 and it might spread
farther north into nonendemic areas of China by
the 2050s.183
Kutz and others have extensively studied the
ecology of host–parasite interactions in the Arctic
environment.184–187 The Artic provides interesting
insights into potential changes in future host–
parasite systems.Helminth parasites (the lungworm
Umingmakstrongylus pallikuukensis and Vare-
strongylus eleguneniensis) affecting muskoxen and
caribou and their gastropod intermediate hosts have
rapidly extended their range at high latitudes in the
central Canadian Arctic. These parasites were found
in the late 2000sonVictoria Island.Their spreadper-
fectly coincidedwith acceleratedwarming across the
region. Cool climatic conditions before the 2000s
may have restricted establishment of lungworms
and intermediate hosts on the island. The spread of
these parasites by migratory caribou is very likely,
and this was further facilitated by rapidly changing
environmental conditions. This is also consistent
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with faster warming occurring at high latitudes and
altitudes; unfortunately, climate models show that
similar trends are likely in future. Furthermore,
muskoxen were severely hit by the direct impacts
of climate change on their environment in 2018.202
Rising temperatures now favor rainfall instead of
snowfall at high latitudes. Once rainfall reaches the
surface, it rapidly freezes, encasing the plants in ice
and making them inaccessible to the animals that
feed on them. Similar trends have been reported in
the SouthernHemisphere, in East Antarctica, where
a colony of about 40,000 Ade´lie penguins died from
starvation in 2017. More recently, in 2016, an out-
break of anthrax, a bacteria present in soil, affected
reindeer en masse in Siberia. Anthrax spores can
survive in frozen animal and human cadavers for
hundreds of years. Following the 2016 reindeer
outbreak, 72 nomadic herders, including 41 chil-
dren, were hospitalized due to subsequent infection
by the bacteria, also known as Siberian plague;
one child died. Experts related this catastrophic
event to unusually warm weather conditions; the
Russian authorities subsequently culled the reindeer
population to limit further spread of anthrax.
Water-borne diseases
Vibrio cholerae, the bacteria that causes cholera,
is naturally present in the environment, in par-
ticular in coastal and estuarine ecosystems. Rita
Colwell devoted her life to studying Vibrio bac-
teria and their ecosystem. V. cholera, like other
species within the genus, attaches to copepods;
the survival of these bacteria and their multipli-
cation consequently rely on plankton population
density and environmental variables such as sea sur-
face temperatures and the input of fresh water.188
Floods combinedwith abnormallywarm sea surface
temperatures favor cholera outbreaks.189 An early
warning system based on climatic variables was
subsequently developed to assess the risk posed by
cholera in Chesapeake Bay, United States. Criti-
cally, the quality of public health services, access
to clean water and sanitation, and political stabil-
ity are basic factors impacting cholera outbreaks; a
prime example is the recent epidemic in Yemen.190
The emergence of many other water-borne dis-
eases is climate sensitive6,191 and strongly associated
with increases in rainfall extremes and hurricanes.
For example, a large cryptosporidium outbreak fol-
lowed floods from the Mississippi in Milwaukee in
1993, and various toxins and norovirus spread in
Katrina’s wake in Louisiana in 2005.192
Recent methodological progress and
research relevance to decision makers
Arguably, themost significant challenge inVBD risk
modeling is the diverse nature, quality, and acces-
sibility of observational datasets, particularly in the
low-income countries which bear the largest burden
of VBDs. This, coupled with the complex, multi-
layer, multiscale, dynamic nature of the disease sys-
tem, has resulted in a huge variety of VBD models,
ranging from global-scale statistical models of risk
to agent-based models that simulate VBD infection
within human hosts at the individual scale.
To date, assessments of the impact of climate
change on future VBD risk have primarily been
carried out at continental to global scales, either
using statistical models linking vector or pathogen
presence to environmental and socioeconomic fac-
tors, or by using a mechanistic approach such as
calculating the disease basic reproduction ratio,
R0, using SEIR/SIR types of models based on dif-
ferential equations or using degree–day types of
models. The two approaches each have advantages
anddisadvantages.193,194While statisticalmodels are
derived directly from observations and may employ
statistical fittingmethods which inherently estimate
their own uncertainty, they generally tend to pro-
duce static maps and do not capture the dynamic
relationship between climate and VBD risk, which
usually follows a seasonal pattern. Furthermore, sta-
tistical models cannot extrapolate risk to differ-
ent scenarios of intervention or climate patterns
beyond those within the training data set. Mech-
anistic models, on the other hand, have the advan-
tage of explicitly modeling the climate–disease risk
relationship, but need detailed information about
vector and pathogen processes to parameterize the
model, and these are often obtained from a collec-
tion of small-scale studies in the laboratory or field.
Additionally, some mechanistic model parameters
rely on laboratory experiments carried out in the
1950s–1960s, and these must be updated for differ-
ent vector–pathogen combinations.195 On a positive
note, this work is in progress. Mechanistic models
also require validationof their simulated risk against
observational data. Long time series are needed to
robustly assess the predictive skill of such mod-
els. When verified as being able to reproduce past
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outbreaks, such models can then be used with sea-
sonal climate forecasts (for a detailed review, see
Ref. 196) or climate change projections to develop
scenarios describing future risk.
It should be noted that mechanistic models based
on R0 have their own limitations due to simplifica-
tion; while useful for large-scale risk assessment,
they do not resolve small spatial and temporal
scale variability, and make simplifying assumptions
regarding homogeneity of the hosts, vectors, and
their interactions. Capturing the heterogeneity in
lower transmission settings has been identified as
a key modeling challenge for malaria,197 and such
settings are often also those most likely to be sensi-
tive to climate. Furthermore, while mechanistic R0
models predict only the suitability of climate con-
ditions for vector or disease transmission if they
are introduced, they do not estimate the probability
of occurrence, which depends on a dispersal route
from endemic regions to unaffected areas.
Recently, some researchers have begun to comb-
inemechanistic and statisticalmodeling approaches
to derive improved VBD risk assessments.198,199
Such methods maybe key in solving the techni-
cal challenges of combining accurate models with
diverse datasets to provide informative risk predic-
tions. High-resolution riskmaps based on statistical
models are very useful resources to inform con-
trol measures in countries plagued by VBD and
estimate spatial patterns of drug and insecticide
resistance,200 a requirement to meet the demand
for locally adapted vector control. But temporal
variability is also important; as Bill Gates recently
said, “Malaria isn’t just patchy. It’s also spiky. We
need to know when those spikes happen, so that
we can mobilize.” Mechanistic VBD models relying
on rainfall and temperature can reproduce spikes of
past VBD outbreaks at broad spatial scales (exam-
ples include the bluetongue outbreak in Northern
Europe in 2006, ZIKV epidemic in South America
in 2015, and historical dengue outbreaks in Mex-
ico and Nicaragua). Consequently, these need to
be tested operationally in collaboration with gov-
ernmental agencies, decision makers, and public
health services, as is currently happening.137 Impor-
tantly, both correlative and mechanistic modeling
approaches have correctly anticipated the spread
of important vectors worldwide; Ae. albopictus in
Europe and I. scapularis in North America are key
examples.
Critically, the interrelatedness of the impacts of
climate changeoneconomics andVBDcontrolmea-
sures needs to be investigated further. There is also
a need for long-term monitoring of vector activ-
ity and the diseases they transmit in order to bet-
ter detect and attribute effects of climate change
on VBD emergence and re-emergence. This can
be achieved by funding health observatories and
improving disease surveillance systems worldwide.
Significant progress has been achieved in terms
of future risk assessment of VBDs over the past
decade. An increasing number of studies now uti-
lize an ensemble of climate models driven by dif-
ferent greenhouse gas emission scenarios, coupled
with different population scenarios to drive future
health impactmodels. This is critical in order to esti-
mate and communicate the related uncertainties,
which can be quite large. Climate model outputs
have to be calibrated with respect to climate obser-
vations, as they still suffer from systematic biases.
Stringent disease model validation over the past is a
prerequisite for providing future projections. As cli-
mate models have benefited from the development
of earth observation systems (satellites and weather
stations), diseasemodel validationswill increasingly
benefit froman improvement in disease surveillance
systems worldwide (e.g., the gold standard Global
Burden of Disease project). Health impact model
intercomparison projects should also be encour-
aged. The climate community has been compar-
ing climate model outputs produced by different
climate centers for many years now (for the Cou-
pled Model InterComparison Project). The impact
modeling community recently started to do so, for
key sectors such as agriculture, water resources, and
health.201 Multidisciplinary research and collabora-
tion between health professionals, epidemiologists,
statisticians, and computer and earth scientists will
be key to anticipating and addressing the health
challenges to come.
Conclusion
There is a wealth of evidence that recent climate
change has already affected pathogen–vector–host
systems, in particular over temperate, peri-Arctic
and Artic areas and high altitude regions in the
tropics. There are now many examples of the early
impacts of climate change on animal VBD bur-
den, while the most severe VBD outbreaks affect-
ing humans tend to be affected by a myriad of
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complex socioeconomic factors and climate. Our
review demonstrates that the spread of vectors
and the pathogens they transmit worldwide has
been anticipated by scientists. Similar trends are
likely in the future if humans fail to mitigate and
adapt to climate change and if drug and insecti-
cide resistance continue to rise. On a positive note,
significant progress has been achieved in terms
of surveillance systems, disease and vector con-
trol measures, vaccine development, diagnostic
tests, and mathematical risk modeling/mapping in
recent decades, thanks to significant funding efforts
from governments, non-governmental organiza-
tions (e.g., charities), and patrons from within the
private sector (e.g., theBill andMelindaGates Foun-
dation).Critically, research funding efforts andpub-
lic health infrastructures need to be sustained if we
do not want to repeat the past.
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